Clinical Trial Update: A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

A global Phase II/III trial evaluating HLX43 as a monotherapy or in combination with HLX07 versus docetaxel in advanced or metastatic squamous non-small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• HLX07 (HLX07)
• HLX43

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Advanced or Metastatic Squamous Non-Small Cell Lung Cancer | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING